Canadian Health Claims for InSea2
Innovactiv says its signature ingredient has two health claims for blood sugar control.
Health Canada has granted two health claims for InSea2 and blood sugar management, says the ingredient’s developer, InnoVactiv (Rimouski, QC, Canada).
InSea2 is a proprietary blend of extracts from brown seaweed (Ascophyllum nodosum) and bladderwrack (Fucus vesiculosus). Under Natural Product Number (NPN) #80033840, qualified products formulated with the InSea2 seaweed extract can run either of the following claims:
- Helps support healthy blood glucose levels
- Helps reduce the glycemic index of ingested foods
Innovactiv says its ingredient can slow the digestion of starch and table sugar, which reduces blood sugar spikes and helps control insulin levels after consuming a meal. The ingredient is backed by clinical studies demonstrating these effects.
“As a critical component of metabolic syndrome, maintaining healthy blood sugar should be at the core of any health-promoting strategy,” says InnoVactiv CEO Patrice Dionne. “Formulating dietary supplements with InSea2 offers a convenient and effective option for those seeking help with their blood sugar level.”
Both Canadian health claims are available for products using InSea2 within a range of 250 to 1000 mg. The company says InSea2 easily incorporates into capsules, tablets, drinks, and functional foods.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
